Brian Bigelow, MD
Interventional Cardiology · Indianapolis, INNPI 1689647216
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 45.2% of the total. 2025 is the largest year on record at $6,665, 8.5 times the $784 reported in 2019.
Across 58 payments — averaging $200.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$2K
- Shockwave Medical, Inc$1K
- Boston Scientific$774
- Biotronik Inc.$357
- Edwards Lifesciences$319
- plus $1K from 10 others
Across 32 payments — averaging $13,520 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$416K
- Surmodics, Inc.$17K
What the payments were for
- Speaking & faculty fees$4,25036%
- Travel & lodging$1,0909%
- Food & beverage$6,31454%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 9 | $5,270 |
| Abbott | 15 | $2,456 |
| Shockwave Medical, Inc | 8 | $1,195 |
| Boston Scientific | 6 | $774 |
| Biotronik Inc. | 3 | $357 |
| Edwards Lifesciences | 3 | $319 |
| Philips North America LLC | 3 | $236 |
| Recor Medical Inc | 2 | $231 |
| Abiomed | 2 | $222 |
| Asahi Intecc USA, Inc. | 1 | $200 |
| Teleflex LLC | 1 | $165 |
| Livanova USA, Inc. | 1 | $143 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Heartflow, Inc. | 1 | $20 |
| Kaneka Medical America LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMPLICITY G3$4,859
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,195
- OPTIS$832
- DRAGONFLY OPSTAR$508
- Orsiro Mission$357
- GENERAL - THERAPIES$283
- PK Papyrus$241
- ONYX FRONTIER$203
- Asahi Coronary Wires$200
- Diamondback Coronary$194
- MitraClip$185
- PARADISE RENAL DENERVATION SYSTEM$168
- GUIDELINER$165
- XIENCE V$162
- SYNERGY$148
- Xience Sierra Coronary Stent System$145
- Xience Sierra Coronary Stent$144
- ProtekDuo$143
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$137
- WATCHMAN Access System$130
How this compares
$11,654 in reported general payments places this provider in the 65th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 166 | $206,583 |
| XareltoRivaroxaban | 32 | $44,019 |
| EntrestoSacubitril/Valsartan | 27 | $31,741 |
| Clonidine | 25 | $6,617 |
| Valsartan | 147 | $5,852 |
| Prasugrel Hcl | 11 | $3,809 |
| Metoprolol Succinate | 237 | $3,194 |
| ClopidogrelClopidogrel Bisulfate | 272 | $2,985 |
| Nebivolol Hcl | 32 | $2,650 |
| Atorvastatin Calcium | 256 | $1,798 |
| Chlorthalidone | 91 | $1,526 |
| Rosuvastatin Calcium | 144 | $1,339 |
| Olmesartan Medoxomil | 68 | $1,024 |
| Nitroglycerin | 59 | $973 |
| Carvedilol | 123 | $972 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Indianapolis
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Michael BallIndianapolis$76K
- Anjan SinhaIndianapolis$54K
- Nitesh GadeelaIndianapolis$48K
- George RevtyakIndianapolis$45K
- Scott SharpIndianapolis$41K
- Amrish MalhiIndianapolis$37K
- Jeffrey BreallIndianapolis$21K
- Sandeep DubeIndianapolis$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.